- Home
- AVIR vs CLPT Comparison
AVIR vs CLPT Comparison
Compare AVIR & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- CLPT
- Stock Information
- Founded
- AVIR 2012
- CLPT 1998
- Country
- AVIR United States
- CLPT United States
- Employees
- AVIR N/A
- CLPT N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- CLPT Medical/Dental Instruments
- Sector
- AVIR Health Care
- CLPT Health Care
- Exchange
- AVIR Nasdaq
- CLPT Nasdaq
- Market Cap
- AVIR 273.0M
- CLPT 315.7M
- IPO Year
- AVIR 2020
- CLPT N/A
- Fundamental
- Price
- AVIR $3.67
- CLPT $12.04
- Analyst Decision
- AVIR Hold
- CLPT Strong Buy
- Analyst Count
- AVIR 1
- CLPT 3
- Target Price
- AVIR $6.00
- CLPT $27.67
- AVG Volume (30 Days)
- AVIR 410.2K
- CLPT 517.1K
- Earning Date
- AVIR 08-06-2025
- CLPT 08-06-2025
- Dividend Yield
- AVIR N/A
- CLPT N/A
- EPS Growth
- AVIR N/A
- CLPT N/A
- EPS
- AVIR N/A
- CLPT N/A
- Revenue
- AVIR N/A
- CLPT $32,235,999.00
- Revenue This Year
- AVIR N/A
- CLPT $23.97
- Revenue Next Year
- AVIR N/A
- CLPT $27.52
- P/E Ratio
- AVIR N/A
- CLPT N/A
- Revenue Growth
- AVIR N/A
- CLPT 23.22
- 52 Week Low
- AVIR $2.46
- CLPT $5.11
- 52 Week High
- AVIR $4.15
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- AVIR 76.11
- CLPT 47.82
- Support Level
- AVIR $3.15
- CLPT $11.19
- Resistance Level
- AVIR $3.35
- CLPT $14.23
- Average True Range (ATR)
- AVIR 0.13
- CLPT 0.69
- MACD
- AVIR 0.03
- CLPT -0.01
- Stochastic Oscillator
- AVIR 83.81
- CLPT 38.10
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.